Zacks: Brokerages Anticipate HealthStream, Inc. (NASDAQ:HSTM) Will Post Earnings of $0.05 Per Share

Wall Street brokerages expect HealthStream, Inc. (NASDAQ:HSTM) to post $0.05 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for HealthStream’s earnings. The lowest EPS estimate is $0.04 and the highest is $0.06. HealthStream posted earnings per share of $0.09 in the same quarter last year, which would indicate a negative year-over-year growth rate of 44.4%. The company is scheduled to announce its next earnings results on Tuesday, February 18th.

On average, analysts expect that HealthStream will report full-year earnings of $0.42 per share for the current financial year, with EPS estimates ranging from $0.39 to $0.44. For the next fiscal year, analysts anticipate that the company will post earnings of $0.37 per share, with EPS estimates ranging from $0.34 to $0.40. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that cover HealthStream.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings data on Tuesday, October 22nd. The technology company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.05. HealthStream had a net margin of 5.92% and a return on equity of 4.14%. The business had revenue of $62.50 million during the quarter, compared to analysts’ expectations of $62.91 million. During the same period last year, the firm posted $0.09 earnings per share. The business’s revenue was up 4.3% on a year-over-year basis.

A number of equities analysts have issued reports on the company. Zacks Investment Research raised HealthStream from a “hold” rating to a “strong-buy” rating and set a $32.00 price target for the company in a research note on Thursday, October 24th. ValuEngine downgraded HealthStream from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. Finally, BidaskClub raised HealthStream from a “sell” rating to a “hold” rating in a research note on Thursday, November 21st. Four investment analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $29.00.

NASDAQ:HSTM traded up $0.05 during midday trading on Friday, hitting $28.72. 184,596 shares of the stock were exchanged, compared to its average volume of 128,016. The company has a market capitalization of $943.18 million, a price-to-earnings ratio of 66.79, a P/E/G ratio of 5.78 and a beta of 0.67. The company has a current ratio of 2.24, a quick ratio of 2.24 and a debt-to-equity ratio of 0.09. HealthStream has a one year low of $23.06 and a one year high of $30.00. The business has a 50-day moving average price of $27.60 and a two-hundred day moving average price of $26.62.

In other news, Director Tate Deborah Taylor sold 6,495 shares of the firm’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $27.96, for a total transaction of $181,600.20. Following the completion of the transaction, the director now owns 16,181 shares in the company, valued at approximately $452,420.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 20.40% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jacobs Levy Equity Management Inc. lifted its stake in HealthStream by 3.2% during the second quarter. Jacobs Levy Equity Management Inc. now owns 172,700 shares of the technology company’s stock valued at $4,466,000 after purchasing an additional 5,320 shares during the last quarter. Panagora Asset Management Inc. boosted its holdings in HealthStream by 0.6% during the second quarter. Panagora Asset Management Inc. now owns 391,521 shares of the technology company’s stock worth $10,125,000 after buying an additional 2,426 shares in the last quarter. Mackay Shields LLC boosted its holdings in HealthStream by 98.7% during the third quarter. Mackay Shields LLC now owns 97,626 shares of the technology company’s stock worth $2,527,000 after buying an additional 48,500 shares in the last quarter. Strs Ohio acquired a new position in HealthStream in the third quarter worth approximately $688,000. Finally, Charles Schwab Investment Management Inc. grew its position in HealthStream by 1.7% in the second quarter. Charles Schwab Investment Management Inc. now owns 150,039 shares of the technology company’s stock worth $3,881,000 after buying an additional 2,522 shares during the last quarter. Institutional investors and hedge funds own 72.34% of the company’s stock.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the training, certification, assessment, development, clinical development, talent management, performance appraisal, and other needs, as well as training, implementation, and account management services for the healthcare community.

Further Reading: 52 Week Highs and Lows

Get a free copy of the Zacks research report on HealthStream (HSTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HealthStream (NASDAQ:HSTM)

Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.